National guidelines version 8th on clinical management of Coronavirus disease by Disease Control Division, Directorate General of Health Services, Ministry of Health & Family Welfare & Government of the People's Republic of Bangladesh. The guideline includes clinical management of COVID-19 and is updated with the latest evide...

An Aid to the Management of COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition This book is a small effort by some highly-motivated Bangladeshi doctors living in the UK and the USA to supplement local guidelines in Bangladesh. This will hopefully enable local experts in Bangladesh to be kept updated...

National guidelines on clinical management of Coronavirus disease by Disease Control Division, Directorate General of Health Services, Ministry of Health & Family Welfare & Government of the People's Republic of Bangladesh.The guideline includes clinical management of COVID-19 and is updated with the latest evidence and the WHO guidelines.

Remdesivir The broad-spectrum antiviral agent remdesivir is a nucleotide analog prodrug. On May 1, 2020, The FDA has granted an emergency use authorization (EUA) for remdesivir to treat hospitalized adults and children with suspected or laboratory-confirmed SARS CoV-2 infection and severe COVID-19 disease.   MANDATORY REQUIREMENTS FOR R...